Evidence showed that high levels of TMEM45A expression in breast and liver cancer cells may be indicative of potential resistance to cancer therapy, making TMEM45A a tumor-promoting factor (Flamant et al., 2012). The gene discussed is TMEM45A; the disease is liver cancer.